Systemic lupus erythematosus (SLE) is characterized by significant mitochondrial dysfunction, where mitochondrial damage releases mtRNA that can be recognized by TLR7, subsequently triggering type I IFN responses (200–202). The gene discussed is TLR7; the disease is systemic lupus erythematosus.